TY - JOUR T1 - Proteinase-Activated Receptor 4 Activation Triggers Cell Membrane Blebbing through RhoA and <em>β</em>-Arrestin JF - Molecular Pharmacology JO - Mol Pharmacol SP - 365 LP - 376 DO - 10.1124/mol.119.118232 VL - 97 IS - 6 AU - Christina M.G. Vanderboor AU - Pierre E. Thibeault AU - Kevin C.J. Nixon AU - Robert Gros AU - Jamie Kramer AU - Rithwik Ramachandran Y1 - 2020/06/01 UR - http://molpharm.aspetjournals.org/content/97/6/365.abstract N2 - Proteinase-activated receptors (PARs) are a four-member family of G-protein–coupled receptors that are activated via proteolysis. PAR4 is a member of this family that is cleaved and activated by serine proteinases such as thrombin, trypsin, and cathepsin-G. PAR4 is expressed in a variety of tissues and cell types, including platelets, vascular smooth muscle cells, and neuronal cells. In studying PAR4 signaling and trafficking, we observed dynamic changes in the cell membrane, with spherical membrane protrusions that resemble plasma membrane blebbing. Since nonapoptotic membrane blebbing is now recognized as an important regulator of cell migration, cancer cell invasion, and vesicular content release, we sought to elucidate the signaling pathway downstream of PAR4 activation that leads to such events. Using a combination of pharmacological inhibition and CRISPR/CRISPR-associated protein 9 (Cas9)–mediated gene editing approaches, we establish that PAR4-dependent membrane blebbing occurs independently of the Gαq/11- and Gαi-signaling pathways and is dependent on signaling via the β-arrestin-1/2 and Ras homolog family member A (RhoA) signaling pathways. Together these studies provide further mechanistic insight into PAR4 regulation of cellular function.SIGNIFICANCE STATEMENT We find that the thrombin receptor PAR4 triggers cell membrane blebbing in a RhoA–and β-arrestin–dependent manner. In addition to identifying novel cellular responses mediated by PAR4, these data provide further evidence for biased signaling in PAR4 since membrane blebbing was dependent on some, but not all, signaling pathways activated by PAR4. ER -